Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM)

Sandro Barni, Marco Venturini, Annamaria Molino, Michela Donadio, Sara Rizzoli, Evaristo Maiello, Stefania Gori

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Aims and background. Project RIGHT (Research for the Identification of the most effective and hIGHly accepted clinical guidelines for cancer Treatment) is promoted by the Italian Association of Medical Oncology (AIOM) to evaluate the concordance between AIOM breast cancer guidelines and clinical practice in Italy. In RIGHT-1, feasibility and the appropriateness of indicators were assessed in patients with early breast cancer. RIGHT-2 evaluated the compliance with guidelines in a nationwide program. Methods. Thirty-five Italian centers participated in the RIGHT-2 survey. Ten indicators were evaluated to verify an agreement between 2005 AIOM breast cancer guidelines and practice. Patients with clinical stage I-II invasive breast cancer, age ≤70 years, who had their first visit at the oncology center between October 2005 and November 2006 were included. Results. In RIGHT-2, ≥90% adherence for the diagnosis indicator and three therapy indicators were observed. The lowest degree of compliance (0%) was observed for the follow-up indicator in asymptomatic patients. Conclusions. In RIGHT-2, compliance to the 2005 AIOMbreast cancer guidelines was 64%.When the follow-up indicator was eliminated, overall adherence to AIOMguidelines was 71%. The results highlight the need to continue improving the already good standards of breast cancer care.

Original languageEnglish
Pages (from-to)559-563
Number of pages5
JournalTumori
Volume97
Issue number5
Publication statusPublished - Sep 2011

Fingerprint

Guideline Adherence
Medical Oncology
Breast Neoplasms
Guidelines
Practice Guidelines
Italy
Compliance
Neoplasms
Therapeutics
Research

Keywords

  • Breast cancer
  • Guideline adherence
  • Italian oncology guidelines

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Barni, S., Venturini, M., Molino, A., Donadio, M., Rizzoli, S., Maiello, E., & Gori, S. (2011). Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM). Tumori, 97(5), 559-563.

Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM). / Barni, Sandro; Venturini, Marco; Molino, Annamaria; Donadio, Michela; Rizzoli, Sara; Maiello, Evaristo; Gori, Stefania.

In: Tumori, Vol. 97, No. 5, 09.2011, p. 559-563.

Research output: Contribution to journalArticle

Barni, S, Venturini, M, Molino, A, Donadio, M, Rizzoli, S, Maiello, E & Gori, S 2011, 'Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM)', Tumori, vol. 97, no. 5, pp. 559-563.
Barni S, Venturini M, Molino A, Donadio M, Rizzoli S, Maiello E et al. Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM). Tumori. 2011 Sep;97(5):559-563.
Barni, Sandro ; Venturini, Marco ; Molino, Annamaria ; Donadio, Michela ; Rizzoli, Sara ; Maiello, Evaristo ; Gori, Stefania. / Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM). In: Tumori. 2011 ; Vol. 97, No. 5. pp. 559-563.
@article{14b3ac78feba4fadbabeaecb367aae7a,
title = "Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM)",
abstract = "Aims and background. Project RIGHT (Research for the Identification of the most effective and hIGHly accepted clinical guidelines for cancer Treatment) is promoted by the Italian Association of Medical Oncology (AIOM) to evaluate the concordance between AIOM breast cancer guidelines and clinical practice in Italy. In RIGHT-1, feasibility and the appropriateness of indicators were assessed in patients with early breast cancer. RIGHT-2 evaluated the compliance with guidelines in a nationwide program. Methods. Thirty-five Italian centers participated in the RIGHT-2 survey. Ten indicators were evaluated to verify an agreement between 2005 AIOM breast cancer guidelines and practice. Patients with clinical stage I-II invasive breast cancer, age ≤70 years, who had their first visit at the oncology center between October 2005 and November 2006 were included. Results. In RIGHT-2, ≥90{\%} adherence for the diagnosis indicator and three therapy indicators were observed. The lowest degree of compliance (0{\%}) was observed for the follow-up indicator in asymptomatic patients. Conclusions. In RIGHT-2, compliance to the 2005 AIOMbreast cancer guidelines was 64{\%}.When the follow-up indicator was eliminated, overall adherence to AIOMguidelines was 71{\%}. The results highlight the need to continue improving the already good standards of breast cancer care.",
keywords = "Breast cancer, Guideline adherence, Italian oncology guidelines",
author = "Sandro Barni and Marco Venturini and Annamaria Molino and Michela Donadio and Sara Rizzoli and Evaristo Maiello and Stefania Gori",
year = "2011",
month = "9",
language = "English",
volume = "97",
pages = "559--563",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM)

AU - Barni, Sandro

AU - Venturini, Marco

AU - Molino, Annamaria

AU - Donadio, Michela

AU - Rizzoli, Sara

AU - Maiello, Evaristo

AU - Gori, Stefania

PY - 2011/9

Y1 - 2011/9

N2 - Aims and background. Project RIGHT (Research for the Identification of the most effective and hIGHly accepted clinical guidelines for cancer Treatment) is promoted by the Italian Association of Medical Oncology (AIOM) to evaluate the concordance between AIOM breast cancer guidelines and clinical practice in Italy. In RIGHT-1, feasibility and the appropriateness of indicators were assessed in patients with early breast cancer. RIGHT-2 evaluated the compliance with guidelines in a nationwide program. Methods. Thirty-five Italian centers participated in the RIGHT-2 survey. Ten indicators were evaluated to verify an agreement between 2005 AIOM breast cancer guidelines and practice. Patients with clinical stage I-II invasive breast cancer, age ≤70 years, who had their first visit at the oncology center between October 2005 and November 2006 were included. Results. In RIGHT-2, ≥90% adherence for the diagnosis indicator and three therapy indicators were observed. The lowest degree of compliance (0%) was observed for the follow-up indicator in asymptomatic patients. Conclusions. In RIGHT-2, compliance to the 2005 AIOMbreast cancer guidelines was 64%.When the follow-up indicator was eliminated, overall adherence to AIOMguidelines was 71%. The results highlight the need to continue improving the already good standards of breast cancer care.

AB - Aims and background. Project RIGHT (Research for the Identification of the most effective and hIGHly accepted clinical guidelines for cancer Treatment) is promoted by the Italian Association of Medical Oncology (AIOM) to evaluate the concordance between AIOM breast cancer guidelines and clinical practice in Italy. In RIGHT-1, feasibility and the appropriateness of indicators were assessed in patients with early breast cancer. RIGHT-2 evaluated the compliance with guidelines in a nationwide program. Methods. Thirty-five Italian centers participated in the RIGHT-2 survey. Ten indicators were evaluated to verify an agreement between 2005 AIOM breast cancer guidelines and practice. Patients with clinical stage I-II invasive breast cancer, age ≤70 years, who had their first visit at the oncology center between October 2005 and November 2006 were included. Results. In RIGHT-2, ≥90% adherence for the diagnosis indicator and three therapy indicators were observed. The lowest degree of compliance (0%) was observed for the follow-up indicator in asymptomatic patients. Conclusions. In RIGHT-2, compliance to the 2005 AIOMbreast cancer guidelines was 64%.When the follow-up indicator was eliminated, overall adherence to AIOMguidelines was 71%. The results highlight the need to continue improving the already good standards of breast cancer care.

KW - Breast cancer

KW - Guideline adherence

KW - Italian oncology guidelines

UR - http://www.scopus.com/inward/record.url?scp=83055163403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83055163403&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 559

EP - 563

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -